Barrett’s Esophagus
Gastroesophageal reflux disease (GERD) is a common condition in America. The most common symptom is heartburn. GERD happens when stomach acid backs up into the esophagus. GERD can increase the risk of developing Barrett’s esophagus.
About 10-15% of people with GERD will develop Barrett’s esophagus. 90% of diagnosed esophageal cancer occurs in patients with no prior history of Barrett’s Esophagus.
Patients diagnosed with Barrett’s Esophagus will be prescribed once daily proton pump inhibitor therapy to reduce stomach acid to help protect your esophagus and reduce the risk of cancer.
Your Gastroenterology Associates of Brooklyn GI doctor will also recommend to stopping smoking or drinking alcohol to reduce your risk of developing esophageal cancer.
Multiple clinical studies report that endoscopic therapy is effective to eliminate precancerous cell changes and early cancer for some patients at high risk. Endoscopic therapy is radiofrequency ablation of the precancerous cells in the esophagus and is an FDA approved technique to treat Barrett’s esophagus. Patients with low risk may benefit from close monitoring of the condition with endoscopies every 12 months in lieu of endoscopic therapy.
Endoscopic radiofrequency ablation is a procedure performed under general anesthesia that uses high-energy radio waves to burn and destroy precancerous cells in the lining of the esophagus.
The good news is that most people with Barrett’s esophagus do not develop cancer. But if you have been diagnosed with this condition, it is important to follow your doctor’s instructions and maintain regular screenings for early detection and treatment. By doing so, you can help keep yourself healthy and reduce your risk of developing esophageal cancer.
Contact Gastroenterology of Brooklyn to schedule a consultation and receive the correct diagnosis and all your treatment options.